Long COVID syndrome: psychological and sexual dysfunction among survivors of COVID-19 infection.
COVID-19
erectile dysfunction
insomnia
libido
long COVID syndrome
neuropsychiatric symptoms
Journal
Annals of medicine and surgery (2012)
ISSN: 2049-0801
Titre abrégé: Ann Med Surg (Lond)
Pays: England
ID NLM: 101616869
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
23
05
2023
accepted:
02
08
2023
medline:
9
10
2023
pubmed:
9
10
2023
entrez:
9
10
2023
Statut:
epublish
Résumé
To explore the neuropsychiatric symptoms, sleep disturbances, and sexual dysfunction in patients with long COVID syndrome, which can help in building better follow-up strategies for coronavirus disease 2019 (COVID-19) survivors. A cross-sectional research was undertaken at the premises of a psychiatry unit at a tertiary care unit in Karachi, Pakistan, between August 2022 and April 2023. All individuals aged 18 years or older, who had a history of contracting COVID-19 infection in the last 12 months presented to the department of Psychiatry with neuropsychiatric symptoms were recruited. Using a predefined questionnaire, data was collected from the participants. A linear logistic regression was used to find the impact of age, sex, hospitalization, and duration of home isolation on the likelihood of persistent neuropsychiatric symptoms or sexual dysfunction. A total of 457 patients were included. It was found that individuals were less likely to experience neuropsychiatric symptoms as age increased (OR=0.968, 95% CI: 0.949-0.986, The majority of the COVID-19 survivors are presenting with persistent neuropsychiatric and sexual symptoms in our setting. Therefore, it is necessary to maintain proper follow-up with the survivors of COVID-19 and counsel the patients to inform the family physician if these symptoms persist for longer than a month. Increasing such practices of regular follow-ups with COVID-19 survivors can help in detecting early neuropsychiatric and sexual changes.
Sections du résumé
Background
UNASSIGNED
To explore the neuropsychiatric symptoms, sleep disturbances, and sexual dysfunction in patients with long COVID syndrome, which can help in building better follow-up strategies for coronavirus disease 2019 (COVID-19) survivors.
Material and methods
UNASSIGNED
A cross-sectional research was undertaken at the premises of a psychiatry unit at a tertiary care unit in Karachi, Pakistan, between August 2022 and April 2023. All individuals aged 18 years or older, who had a history of contracting COVID-19 infection in the last 12 months presented to the department of Psychiatry with neuropsychiatric symptoms were recruited. Using a predefined questionnaire, data was collected from the participants. A linear logistic regression was used to find the impact of age, sex, hospitalization, and duration of home isolation on the likelihood of persistent neuropsychiatric symptoms or sexual dysfunction.
Results
UNASSIGNED
A total of 457 patients were included. It was found that individuals were less likely to experience neuropsychiatric symptoms as age increased (OR=0.968, 95% CI: 0.949-0.986,
Conclusion
UNASSIGNED
The majority of the COVID-19 survivors are presenting with persistent neuropsychiatric and sexual symptoms in our setting. Therefore, it is necessary to maintain proper follow-up with the survivors of COVID-19 and counsel the patients to inform the family physician if these symptoms persist for longer than a month. Increasing such practices of regular follow-ups with COVID-19 survivors can help in detecting early neuropsychiatric and sexual changes.
Identifiants
pubmed: 37811042
doi: 10.1097/MS9.0000000000001153
pii: AMSU-D-23-01133
pmc: PMC10553038
doi:
Banques de données
figshare
['10.6084/m9.figshare.23608491.v1']
Types de publication
Journal Article
Langues
eng
Pagination
4788-4793Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Références
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Neurol Sci. 2022 Mar 15;434:120162
pubmed: 35121209
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Int J Environ Res Public Health. 2021 Aug 12;18(16):
pubmed: 34444288
J Infect Dis. 2022 Nov 1;226(9):1593-1607
pubmed: 35429399
Brain Commun. 2021 Dec 17;4(1):fcab297
pubmed: 35169700
Rev Colomb Psiquiatr (Engl Ed). 2021 Jul 2;:
pubmed: 34230698
Med Pr. 2021 Dec 22;72(6):711-720
pubmed: 34850782
Int J Impot Res. 2022 Mar;34(2):145-151
pubmed: 34992226
Nat Med. 2021 Sep;27(9):1607-1613
pubmed: 34163090
Clin Microbiol Infect. 2022 Apr;28(4):611.e9-611.e16
pubmed: 34763058
Front Aging Neurosci. 2020 Oct 26;12:588872
pubmed: 33192483
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Infect Dis (Lond). 2021 Oct;53(10):737-754
pubmed: 34024217
Allergy Asthma Proc. 2022 May 1;43(3):187-193
pubmed: 35524358
J Headache Pain. 2022 Aug 12;23(1):101
pubmed: 35962348
Front Immunol. 2021 Jun 30;12:686029
pubmed: 34276671
Neurology. 2020 Sep 29;95(13):559-560
pubmed: 32788251
Int J Surg. 2021 Dec;96:106165
pubmed: 34774726
ACS Chem Neurosci. 2021 Feb 17;12(4):573-580
pubmed: 33538586
Ann N Y Acad Sci. 2021 Feb;1486(1):90-111
pubmed: 33009668